BioAge Labs, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$7,767,433
10 notices · 440,689 sh
Oct 2025 to Oct 2026
Reported ·
$6,216,660
11 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
All 11 reported sales carry the 10b5-1 box. Together they are 0.82% of the shares on issue.
under a ▼ salesize is dollars
Form 144 notices, newest first
2026-06-30Barton Shane, Principal Accounting Officer$509,177
2026-06-29Barton Shane, Principal Accounting Officer$1,067,578
2026-04-01RUBIN PAUL D, Chief Medical Officer$157,084
Form 4, 2026-04-03: sold 8,820 at $17.81 Form 4 ↗
2026-03-02RUBIN PAUL D, Chief Medical Officer$148,883
Form 4, 2026-03-03: sold 7,433 at $20.30 Form 4 ↗
2026-02-02RUBIN PAUL D, Chief Medical Officer$139,369
Form 4, 2026-02-03: sold 7,433 at $18.75 Form 4 ↗
2026-01-13Fortney Kristen, Chief Executive Officer$4,195,926
Form 4, 2026-01-15: sold 233,107 at $18.12 Form 4 ↗
2026-01-13GOLDSTEIN DOV A MD, Chief Financial Officer$531,828
Form 4, 2026-01-15: sold 27,000 at $19.70 Form 4 ↗
2026-01-02RUBIN PAUL D, Chief Medical Officer$99,677
Form 4, 2026-01-06: sold 7,433 at $12.85 Form 4 ↗
2025-12-09RUBIN PAUL D, Chief Medical Officer$216,000
Form 4, 2025-12-11: sold 18,000 at $12.00 Form 4 ↗